Background/Objectives: To create an open-source method for reconstructing microelectrode recording (MER) and deep brain stimulation (DBS) electrode coordinates along multiple parallel trajectories with patient-specific DBS implantation platforms to facilitate DBS research. Methods: We combined the surgical geometry (extracted from WayPoint Planner), pre-/intra-/postoperative computed tomography (CT) and/or magnetic resonance (MR) images, and integrated them into the Analysis of Functional NeuroImages (AFNI) neuroimaging analysis environment using functions written in Python. Electrode coordinates were calculated from image-based electrode surfaces and recording trajectory depth values. Coordinates were translated into appropriate trajectories, and were tested for proximity to patient-specific or atlas-based anatomical structures. Final DBS electrode coordinates for 3 patient populations (ventral intermediate nucleus [VIM], subthalamic nucleus [STN], and globus pallidus pars interna [GPi]) were calculated. For STN cases, MER site coordinates were then analyzed to see whether they were inside or outside the STN. Results: Final DBS electrode coordinates were described for VIM, STN, and GPi patient populations. 115/169 (68%) STN MER sites were within 1 mm of the STN in AFNI’s Talairach and Tournoux (TT) atlas. Conclusions: DBStar is a robust tool kit for understanding the anatomical location and context of electrode locations, and can easily be used for imaging, behavioral, or electrophysiological analyses.

1.
Gross RE, Krack P, Rodriguez-Oroz MC, Rezai AR, Benabid A-L: Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson’s disease and tremor. Mov Disord Off J Mov Disord Soc 2006; 21(suppl 14):S259–S283.
2.
Konrad PE, Neimat JS, Yu H, Kao CC, Remple MS, D’Haese P-F, et al: Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008. Stereotact Funct Neurosurg 2011; 89: 34–41.
3.
D’Haese P-F, Pallavaram S, Konrad PE, Neimat J, Fitzpatrick JM, Dawant BM: Clinical accuracy of a customized stereotactic platform for deep brain stimulation after accounting for brain shift. Stereotact Funct Neurosurg 2010; 88: 81–87.
4.
Lauro PM, Vanegas-Arroyave N, Huang L, Taylor PA, Zaghloul KA, Lungu C, et al: DBSproc: an open source process for DBS electrode localization and tractographic analysis. Hum Brain Mapp 2016; 37: 422–433.
5.
Cox RW: AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996; 29: 162–173.
6.
Saad ZS, Reynolds RC: SUMA. NeuroImage 2012; 62: 768–773.
7.
Taylor PA, Saad ZS: FATCAT: (an efficient) functional and tractographic connectivity analysis toolbox. Brain Connect 2013; 3: 523–535.
8.
Akbar U, Asaad WF: A comprehensive approach to deep brain stimulation for movement disorders. R I Med J 2017; 100: 30–33.
9.
Rorden C, Brett M: Stereotaxic display of brain lesions. Behav Neurol 2000; 12: 191–200.
10.
Fischl B: FreeSurfer. NeuroImage 2012; 62: 774–781.
11.
Lancaster JL, Rainey LH, Summerlin JL, Freitas CS, Fox PT, Evans AC, et al: Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum Brain Mapp 1997; 5: 238–242.
12.
Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al: Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000; 10: 120–131.
13.
Reveley C, Gruslys A, Ye FQ, Glen D, Samaha J, Russ BE, et al: Three-dimensional digital template atlas of the macaque brain. Cereb Cortex 2017; 27: 4463–4477.
14.
Al-Helli O, Thomas DL, Massey L, Foltynie T, Limousin P, Holton JL, et al: Deep brain stimulation of the subthalamic nucleus: histological verification and 9.4-T MRI correlation. Acta Neurochir 2015; 157: 2143–2147.
15.
van Kuyck K, Welkenhuysen M, Arckens L, Sciot R, Nuttin B: Histological alterations induced by electrode implantation and electrical stimulation in the human brain: a review. Neuromodulation 2007; 10: 244–261.
16.
Sun DA, Yu H, Spooner J, Tatsas AD, Davis T, Abel TW, et al: Postmortem analysis following 71 months of deep brain stimulation of the subthalamic nucleus for Parkinson disease. J Neurosurg 2008; 109: 325–329.
17.
Pallavaram S, Dawant BM, Remple MS, Neimat JS, Kao C, Konrad PE, et al: Effect of brain shift on the creation of functional atlases for deep brain stimulation surgery. Int J Comput Assist Radiol Surg 2010; 5: 221–228.
18.
Sharim J, Pezeshkian P, DeSalles A, Pouratian N: Effect of cranial window diameter during deep brain stimulation surgery on volume of pneumocephalus. Neuromodulation 2015; 18: 574–578–579.
19.
Sillay KA, Kumbier LM, Ross C, Brady M, Alexander A, Gupta A, et al: Perioperative brain shift and deep brain stimulating electrode deformation analysis: implications for rigid and non-rigid devices. Ann Biomed Eng 2013; 41: 293–304.
20.
Slotty PJ, Kamp MA, Wille C, Kinfe TM, Steiger HJ, Vesper J: The impact of brain shift in deep brain stimulation surgery: observation and obviation. Acta Neurochir 2012; 154: 2063–2068; discussion 2068.
21.
Horn A, Kühn AA: Lead-DBS: A toolbox for deep brain stimulation electrode localizations and visualizations. NeuroImage 2015; 107: 127–135.
22.
D’Albis T, Haegelen C, Essert C, Fernández-Vidal S, Lalys F, Jannin P: PyDBS: an automated image processing workflow for deep brain stimulation surgery. Int J Comput Assist Radiol Surg 2015; 10: 117–128.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.